Acute pain, typically a transient and protective response to tissue injury or disease, remains a significant clinical challenge with substantial healthcare burdens if unmanaged. Its well-understood pathophysiological mechanisms, involving neuro-mediator release (e.g., bradykinin, serotonin) following noxious stimuli, form the basis for developing sophisticated preclinical models.
